CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,861,000 | +75.7% | 36,026 | -15.7% | 0.02% | +112.5% |
| Q2 2022 | $1,059,000 | -7.9% | 42,736 | -6.9% | 0.01% | +14.3% |
| Q1 2022 | $1,150,000 | -21.7% | 45,886 | +13.7% | 0.01% | -12.5% |
| Q4 2021 | $1,469,000 | +49.1% | 40,357 | -29.9% | 0.01% | +33.3% |
| Q3 2021 | $985,000 | +11.9% | 57,581 | -12.4% | 0.01% | +20.0% |
| Q2 2021 | $880,000 | -49.4% | 65,742 | +93.6% | 0.01% | -54.5% |
| Q1 2021 | $1,740,000 | -17.5% | 33,966 | -0.3% | 0.01% | -15.4% |
| Q4 2020 | $2,108,000 | – | 34,052 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |